Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies

التفاصيل البيبلوغرافية
العنوان:	Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies
المؤلفون:	Bi-Cheng Wang, Bo-Ya Xiao, Guo-He Lin
المصدر:	BMC Cancer, Vol 22, Iss 1, Pp 1-10 (2022)
بيانات النشر:	BMC, 2022.
سنة النشر:	2022
المجموعة:	LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية:	Ewing sarcoma, Irinotecan, Temozolomide, Chemotherapy, Integrated analysis, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
الوصف:	Highlights 1. Nearly 44% of relapsed Ewing sarcoma patients achieved an ORR after IT treatment. 2. Relapsed Ewing sarcoma treated with IT had an over 66% DCR. 3. IT chemotherapy caused low incidences of neutropenia, thrombocytopenia, and diarrhea in treating relapsed Ewing sarcoma.
نوع الوثيقة:	article
وصف الملف:	electronic resource
اللغة:	English
تدمد:	1471-2407
Relation:	https://doaj.org/toc/1471-2407
DOI:	10.1186/s12885-022-09469-5
URL الوصول:	https://doaj.org/article/d79cff8793fb41fe9ecb551c7a9f6990
رقم الأكسشن:	edsdoj.79cff8793fb41fe9ecb551c7a9f6990
قاعدة البيانات:	Directory of Open Access Journals

الوصف
تدمد:	14712407
DOI:	10.1186/s12885-022-09469-5